Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease

Abstract

Patients with LE-PAD with high-risk limb presentations or high-risk comorbidities had a high incidence of major vascular events. For these patients, treatment with rivaroxaban and aspirin in combination compared with aspirin alone led to a large absolute reduction in vascular risk.